The Vaccine and Treatment Evaluation Unit at Baylor College of Medicine has been selected as one of nine sites funded by the National Institutes of Health that will take part in studies to test vaccines to protect against the avian influenza (“bird flu”) strain called H7N9.  

This deadly new strain hit China last spring and researchers hope to develop effective vaccines that could be used if a pandemic caused by this virus develops.

Researchers at BCM are recruiting adults between the ages of 19 and 64 who are in good health. Study participants will receive different dosages of an investigational vaccine given with or without one of two adjuvants, which are substances added to a vaccine to increase the body’s immune response. Researchers then will gather information regarding the safety, tolerability and antibody responses following vaccination.

For more information on how to take part in the study at BCM, call the BCM Vaccine Research Center at (713) 798-4912.